Economic Evaluation of Alternative Strategies to Treat Patients with Diabetes Mellitus and Coronary Artery Disease
- 1 June 2006
- journal article
- research article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 97 (12), 59-65
- https://doi.org/10.1016/j.amjcard.2006.03.014
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Medical economics and the assessment of value in cardiovascular medicine: Part II.Circulation, 2002
- Medical economics and the assessment of value in cardiovascular medicine: Part I.Circulation, 2002
- Introduction to health economics for physiciansThe Lancet, 2001
- Effect of Improved Glycemic Control on Health Care Costs and UtilizationJAMA, 2001
- Cost effectiveness of an intensive blood glucose control policy in patients with type 2 diabetes: economic analysis alongside randomised controlled trial (UKPDS 41)BMJ, 2000
- Health Economic Benefits and Quality of Life During Improved Glycemic Control in Patients With Type 2 Diabetes MellitusJAMA, 1998
- Economic Assessment of Low-Molecular-Weight Heparin (Enoxaparin) Versus Unfractionated Heparin in Acute Coronary Syndrome PatientsCirculation, 1998
- Lifetime Benefits and Costs of Intensive Therapy as Practiced in the Diabetes Control and Complications TrialJAMA, 1996
- Resource Utilization and Costs of Care in the Diabetes Control and Complications TrialDiabetes Care, 1995
- The Effect of Intensive Treatment of Diabetes on the Development and Progression of Long-Term Complications in Insulin-Dependent Diabetes MellitusNew England Journal of Medicine, 1993